Medicare finally covers residential addiction treatment for seniors—with a catch.
H.R. 9538 — Residential Recovery for Seniors Act · Filed by Lauren Underwood (D-IL) · 8 cosponsors · Introduced Jun 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare coverage to include residential substance use disorder treatment services for seniors, establishing three tiers of care (clinically managed low-intensity, clinically managed high-intensity, and medically managed) with defined facility standards, clinical requirements, and a per-diem payment system beginning October 1, 2026. Medicare will pay for bed, board, clinical services, medications, and support services at these facilities, with payment rates initially set to cover 100% of reasonable costs and adjusted annually by market-basket inflation.
Why we flagged it
The bill's core function is to add a new category of covered services under Medicare Part A—residential substance use disorder treatment—with defined facility types, clinical standards, and a prospective payment system. This is straightforward healthcare coverage expansion, not a hidden mechanism or rider.
What the text implies
- The bill delegates clinical standard-setting to 'a nonprofit medical association generally recognized for its expertise in addiction treatment' without naming the organization, creating potential regulatory capture if a single association dominates standard-setting and certification.
- Payment rates are set at 100% of 'reasonable costs' in year one, with no explicit cost-control mechanism beyond market-basket inflation in subsequent years; if facilities inflate baseline costs, the inflation adjustment perpetuates overpayment.
- The bill requires facilities to be 'accredited by an accrediting body approved by Sec.' but does not specify accreditation standards, creating discretion for the Secretary to approve bodies with varying rigor.
- Medically managed facilities must provide '24-hour nursing services' but the bill does not specify nurse-to-patient ratios or staffing minimums, leaving quality and safety standards to future regulation.
- The prospective payment system applies only to residential facilities; outpatient and partial hospitalization addiction services remain under different payment rules, potentially creating incentives to admit patients to residential settings even when less intensive care would suffice.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Seniors with substance use disorders gain access to a previously uncovered category of residential treatment through Medicare, addressing a significant gap in addiction care for older adults. The bill establishes clinical standards and oversight mechanisms to ensure quality care, though the full public benefit depends on implementation and whether facilities can meet the defined standards.
Who stands to gain
- residential substance use disorder treatment facilities (private and nonprofit operators)
- addiction medicine providers and clinicians
- pharmaceutical companies (increased demand for addiction medications, particularly buprenorphine and
- accrediting bodies and certification organizations
Named in the bill
Medicare (Centers for Medicare & Medicaid Services), Social Security Act (Title XVIII), residential substance use disorder facilities, nonprofit medical associations (addiction treatment expertise), accrediting bodies, Secretary of Health and Human Services, BMY (Bristol Myers Squibb), GH (Guardant Health), PFE (Pfizer), DVA (DaVita HealthCare Partners), JNJ (Johnson & Johnson)
Where it stands
8 cosponsors: 5 Republicans, 3 Democrats.
- Jun 30, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jun 30, 2026 — Referred to House Committee on Ways and Means · Congress.gov: “Referred to the House Committee on Ways and Means”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $40,000 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Lauren Underwood, the sponsor, reported $424,700 in PAC receipts in the 2026 cycle.
- American Society of Addiction Medicine — $40,000 on 1 filing
Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (23,567 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 17, 2026 · page rendered 2026-10-20.
“Medicare finally covers residential addiction treatment for seniors—with a catch.” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9538 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.